Managing Medical Risk In Patients Seeking Psilocybin Therapy
Log In To Access the Course
*Not yet enrolled in the course? See purchase options below.
Jointly provided by Postgraduate Institute for Medicine and the Psychedelic Medicine Association - Released April 27, 2023
Managing Medical Risk In Patients Seeking Psilocybin Therapy
Course
- Self-Paced - Online
- CME/CE Accreditation
- 2 hours
- Option to join our public directory of practitioners upon completion
PMA Membership
- Monthly webinars with experts in the field
- Monthly psychedelic science newsletter with the latest research
- Members-only community groups
- Journal clubs
Share:
Facebook
Twitter
LinkedIn
Module Breakdown
Module 1: Background on Psilocybin
Module 2: Psilocybin Legality & the Oregon Psilocybin Services Act
Module 3: Research-Investigated Indications
Module 4: Managing Medical Risk in Patients Seeking Psilocybin Therapy
General Information
- Jointly provided by Postgraduate Institute for Medicine and the Psychedelic Medicine Association
- Release date: April 27, 2023
- Expiration date: April 27, 2024
- Estimated time to complete activity: [2] hours
Target Audience
This activity is intended for all providers delivering primary care to adults, and to all health practitioners such as psychiatrists and psychiatric nurse practitioners.
Educational Objectives
After completing this activity, the participant should be better able to:
- Gain a basic understanding of what psilocybin and psilocybin mushrooms are and their historical use
- Identify the indications for which psilocybin has been researched
- Understand the contraindications to psilocybin therapy and how psilocybin affects the mind and body
- Understand psilocybin’s pharmacology and drug-drug interactions
Faculty
Lynn Marie Morski, MD, JD
President, Psychedelic Medicine Association; Host, Psychedelic Medicine Podcast
Lynn Marie Morski, MD, JD, is president of the Psychedelic Medicine Association and host of the Psychedelic Medicine Podcast. She sits on the advisory boards of VETS, Inc (Veterans Exploring Treatment Solutions), Psychedelics Today, Ketamine Task Force, and Cybin. Dr. Morski received her medical degree from St. Louis University School of Medicine, completed family medicine residency at Mayo Clinic, and did her sports medicine fellowship at the University of Arizona. She later received her law degree from Thomas Jefferson School of Law and is a member of the California Bar.
Consultant/Advisory Board:
- Cybin
- Oxenberg Foundation
- Psychedelics Today
Non-Mutual funds/Stock Ownership/Stock options:
- Cybin
Reid Robison, MD MBA
Chief Clinical Officer, Numinus; Board Member, Psychedelic Medicine Association
Dr. Reid Robison is a board-certified psychiatrist and Chief Clinical Officer at Numinus, and oversees the clinical services, including teaching and training in ketamine-assisted psychotherapy, for the company’s clinics across the US and Canada. He has led over 200 clinical trials in neuropsychiatry, and previously served as coordinating investigator for the MAPS-sponsored MDMA-assisted psychotherapy study of eating disorders. He is currently principal investigator for a number of psychedelic medicine studies with psilocybin, LSD and DMT. As an early adopter and researcher of ketamine in psychiatry, Dr. Robison got his first grant to study ketamine in 2011, and around that time also led a pivotal IV ketamine study for treatment-resistant depression by Janssen. To date, Dr. Robison has guided thousands of ketamine therapy journeys and Spravato dosing sessions, and has worked in ayahuasca retreat settings abroad. Dr. Robison is also an adjunct professor at both the University of Utah and Brigham Young University.
Reid Robison, MD, MBA
Employee/Owner:
- Numinus Wellness
- Center for Change
Grant/Research Support:
- Usona Institute
- MindMed
- Janssen
- Merck
- Neurocrine Bioscience
- Alto Neuroscience
- Clexio Biosciences
- Otsuka
Speakers Bureau/Honoraria for non-CME:
- Janssen
Consultant/Advisory Board:
- Apex Neuroscience
- MAPS PBC
Non-Mutual funds
- Numinus Wellness
Benjamin Malcolm, PharmD, MPH, BCPP
Founder, Spirit Pharmacist LLC
Dr. Ben Malcolm earned his bachelor’s degree (BS) in pharmacology at the University of California at Santa Barbara, prior to his Masters in Public Health (MPH) and Doctorate of Pharmacy (PharmD) at Touro University California. He then completed post-graduate residencies in Acute Care at Scripps Mercy Hospital and Psychiatric Pharmacy at the University of California at San Diego Health.
After residency he passed his exam to become Board Certified in Psychiatric Pharmacy (BCPP). He began his career as an Assistant Clinical Professor at Western University of Health Sciences (WUHS), College of Pharmacy before transitioning to his current entrepreneurial role as a Psychopharmacology Consultant, Psychedelic Educator, and Founder of Spirit Pharmacist.
Ben envisions a society in which access to psychedelic drugs in a variety of safe and supported settings is available for purposes of psychospiritual well-being, personal development, ceremonial sacraments, and treatment of mental illness. His focus is on the intersection between psychiatric medications and psychedelic therapies. He has given several Continuing Education presentations to pharmacists and other healthcare professionals as well as published over a dozen articles in peer-reviewed literature relating to psychedelics or psychiatric medications.
His vision guides his clinical and education service-related professional activity.
Speakers Bureau/Honoraria for non-CME:
- F.I.V.E 5-MeO-DMT
- Synthesis Institute Psilocybin Facilitator Training
- ATMA Advanced and Prescriber Course
- Entheonation – Plant Spirit School
- PsychedSoul Integration Playskool
Consultant/Advisory Board:
- Psychedelic Medicine Association
- Kaivalya Kollectiv
- PsychedeLiA Integration
Non-Mutual funds Stock Ownership/Stock options:
- Kaivalya Kollectiv
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity. These relationships have been mitigated.
Method of Participation and Request for Credit
In order to obtain your CE certificate, please follow the steps below at the conclusion of the activity:
- Go to www.cmeuniversity.com
- Login or Create a New Account (will take less than 1 minute)
- If you receive a message when creating a new account that “the email you entered is already in use”, please click the Forgot my Username or Password link to have your Username and Password sent to you via email
- After logging in, you may be asked to verify/update your information; after doing so, click Save at the bottom of the page
- Type in 17861 at the top of the page, “Find Post-Test/Evaluation by Course”, and click enter
- Click on the activity title when it appears
- Choose the type of credit you desire
- (If applicable) Complete the Post-test with a passing score of 75% or better
- Complete the online Evaluation
- Receive an immediate CE Certificate to download and/or print for your files
If you have questions regarding the certification of this activity, please contact PIM via email at [email protected].
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and the Psychedelic Medicine Association. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 2 contact hours. (If applicable, for APRNs, enduring activity)
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2 APA Category 1 CME credits. Approval is valid until April 27, 2024. PAs should only claim credit commensurate with the extent of their participation.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
FAQs
The purpose of this course is to educate healthcare providers so that when patients ask if psilocybin therapy is appropriate for them, those providers will be able to do an informed risk assessment with the patient.
In order to get clinicians comfortable with having these conversations and doing these assessments, the course covers the basics of psilocybin therapy, the indications for which psilocybin therapy has shown promise in clinical research, the pharmacology of psilocybin (including drug-drug interactions), and the medical risks associated with psilocybin therapy.
This course is intended for healthcare providers who see patients primarily in a primary care setting. The course is intended to teach practitioners how to do a risk assessment based on both mental and physical health factors, so the course is intended for any practitioner who evaluates both for their patients.
Our course is open to clinicians who are members of the Psychedelic Medicine Association, which is open to licensed healthcare providers, healthcare trainees, and students in healthcare-related programs.
The course is self-paced and consists of four modules, each taking approximately 30 minutes to complete. So, the total duration of the course is about two hours resulting in two CME/CE hours.
After completing this activity, the participant should be better able to:
- Gain a basic understanding of what psilocybin and psilocybin mushrooms are and their historical use
- Identify the indications for which psilocybin has been researched
- Understand the contraindications to psilocybin therapy and how psilocybin affects the mind and body
- Understand psilocybin’s pharmacology and drug-drug interactions
The course is structured into four modules, each containing lecture slides. There is also a final exam at the end of the course.
Yes, here are the accreditations:
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 2 contact hours. (If applicable, for APRNs, enduring activity)
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2 APA Category 1 CME credits. Approval is valid until April 27, 2024. PAs should only claim credit commensurate with the extent of their participation.
The course is available to members of the Psychedelic Medicine Association. The cost of the course is $100.
Yes, upon successfully completing the course and passing the final exam, you will be redirected to a page with instructions for obtaining your certificate through CME University.
No, this course is not meant to provide you with the necessary qualifications to provide psilocybin therapy. It is meant to provide you with the knowledge and tools to manage medical risks associated with psilocybin therapy.
You can enroll by clicking any of the “enroll now” buttons towards the top of this page which will redirect you to a checkout page. If you’re not yet a member of the Psychedelic Medicine Association, you will be prompted to sign up. Once you’ve registered and verified your account, you’ll be emailed an enrollment confirmation with a link to access the course. If you’re having any issues contact support at [email protected].
Once you are a member and have enrolled, you will be emailed a link to access the course which you can return to at any point if you are unable to complete the course in one sitting. You can also access the course content by returning to the course page, where you are now, and logging in using the widget at the top of the page if you aren’t already. Once you’re logged in, you will see the different modules for the course displayed at the top of the page. Click on the module where you left off and you will be redirected to begin the relevant course page. If you’re having any issues contact support at [email protected].